SLU-PP-332 in Australia

Legal status, what it is, and the listed suppliers in Australia that list it.

Legal status in Australia

Not an approved medicine. Not listed by name in the Poisons Standard (June 2026).

As understood at 2026-09-22. Verify with the TGA.

What SLU-PP-332 is

SLU-PP-332 is a synthetic small molecule, not a peptide. It is an agonist of the estrogen-related receptors (ERR alpha, beta and gamma), a family of nuclear receptors involved in mitochondrial and oxidative metabolism gene programmes, and was made as a research tool compound. It has a page here because several listed suppliers sell it alongside their peptides.

Full SLU-PP-332 page: targets and research →

Listed suppliers in Australia

2 of the 10 suppliers we list in Australia list SLU-PP-332. Listed, not endorsed: each row is the supplier’s own stated terms.

Aussie Peptides Australia Research use only. Statements have not been evaluated by the TGA. We do not ship internationally at this time. Australian Peptide Site Australia Intended for laboratory and scientific research use only.

Clinical Research

Targeting ERRs to counteract age-related muscle atrophy associated with physical inactivity: a pilot study

Bonanni R, Falvino A, Matticari A, et al. (2025). Frontiers in Physiology. in-vitro muscle biopsies from 20 women undergoing hip replacement (10 active, 10 inactive); primary myoblasts from the inactive group treated in culture